Toward Disease-Modifying Therapies in Type 1 Diabetes: Focus on Teplizumab. Mathieu C, Sims EK, Chatenoud L, James EA, et al. Diabetes Care 2025 Nov 6:dci250066. doi: 10.2337/dci25-0066.

Read + Share

Amedeo Smart

Independent Medical Education

Mathieu C, Sims EK, Chatenoud L, James EA, et al. Toward Disease-Modifying Therapies in Type 1 Diabetes: Focus on Teplizumab. Diabetes Care 2025 Nov 6:dci250066. doi: 10.2337/dci25-0066.
PMID: 41196630